The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. B.S. Ajaikumar and members of the BSA Promoter Group have disclosed an encumbrance on their shares in HealthCare Global Enterprises under Regulation 31(1) of SEBI SAST Regulations. The encumbrance is not a typical financial pledge but a contractual restriction on transfer of shares, created on 30 May 2025, in favor of Hector Asia Holdings II Pte. Ltd. and KIA EBT II Scheme 1 under a Promoter Agreement dated 23 February 2025. A total of 49,59,539 shares (3.56% of total share capital) held by Dr. B.S. Ajaikumar are subject to this restriction, while the other family members' shares show 0% encumbered. The encumbrance is 5.7% of promoter shareholding, well below the 50% promoter shareholding and 20% of total share capital thresholds.
This is a procedural disclosure of contractual transfer restrictions arising from the existing Promoter Agreement with the Purchasers (Hector Asia and KIA EBT II). It is not a financial distress signal — no borrowing is involved, and the encumbrance size is small relative to both promoter holdings and total share capital. Shareholders should not view this negatively.